Home
News
Create
Screeners
Insights
Boston Commerce
6.
67
-0.13
(-1.91%)
Market Cap
₹4.71 Cr
PE Ratio
-8.19
Industry
Healthcare Services
Buy
Sell
Company Performance:
1D
-1.91%
1M
-14.38%
6M
-8.00%
1Y
-7.49%
5Y
-68.09%
View Company Insights
Latest news about Boston Commerce
Boston Commerce board to consider share capital reduction
8 days ago
Boston Commerce Limited will hold a board meeting on June 05, 2026, to consider a proposal for reducing its share capital, subject to approvals under the Companies Act, 2013.
Boston Commerce reports net loss of ₹58.08 lakh in FY26
10 days ago
Boston Bio Systems Limited Officially Changes Name to Boston Commerce Limited Effective February 20, 2026
Feb 17, 2026
Boston Commerce Limited Reports Q3FY26 Results with Revenue Decline and Net Loss
Feb 13, 2026
Boston Bio Systems Limited Rebrands as Boston Commerce Limited
Nov 27, 2025
More news about Boston Commerce
14
Nov 25
Boston Bio Systems Reports Q2 Profit, Appoints New Auditors
Boston Bio Systems Ltd. (BSE: BOSTONBIO) announced financial results for Q2 and H1 FY2025-26, showing significant improvement. Q2 revenue was ₹24.47 crore with a profit after tax of ₹3.94 crore, compared to a loss in the previous year. H1 revenue reached ₹42.52 crore with ₹7.95 crore profit. The company also appointed Mr. Shashank Kumar as Secretarial Auditor and Mr. Nishant Sharma as Internal Auditor for FY2025-26.
13
Oct 25
Boston Bio Systems Limited Announces Key Leadership Changes in Company Secretarial Position
Boston Bio Systems Ltd. has appointed Ms. Nisha Yadav as the new Company Secretary and Compliance Officer, effective October 13, 2025. She replaces Ms. Mandeep Kaur, who has resigned from the position. Ms. Yadav is a qualified Company Secretary with over 4 years of experience in corporate law matters. The changes were approved by the Board of Directors based on the recommendation of the Nomination and Remuneration Committee.
04
Sept 25
Boston Bio Systems Announces Major Corporate Changes, Including New Auditor Appointment
Boston Bio Systems Ltd. (BSE: 531458) has announced significant corporate changes following a board meeting. The company appointed M/s Sunit M Chhatbar & Co. as the new Statutory Auditor, replacing M/s Nahar V & Company. The Board approved changes to the Memorandum of Association, expanding potential business activities to include IT services, agriculture, real estate, and e-commerce. A new set of Articles of Association was also approved. These changes are subject to shareholder approval at the upcoming 30th Annual General Meeting.
Boston Commerce
6.
67
-
0.
13
(-
1.
91
%)
1 Year Returns:
-7.49%
Industry Peers
Dr. Lal Path Labs
1,575.80
(+
1.
93
%)
Vijaya Diagnostic Centre
1,296.20
(-
0.
87
%)
Metropolis Healthcare
535.55
(+
1.
11
%)
Thyrocare Technologies
547.95
(+
1.
22
%)
Nephrocare Health Services
709.25
(+
6.
65
%)
Krsnaa Diagnostics
544.35
(+
1.
65
%)
Suraksha Diagnostic
269.65
(-
2.
19
%)
One Global Service Provider
589.00
(+
3.
41
%)
3B BlackBio DX
1,201.50
(+
4.
08
%)
Health X Platform
293.20
(-
2.
45
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar